Some Seizure Medicines In Pregnancy Linked To Lower Child IQ

What was studied

This Australian semiprospective cohort study looked at whether children exposed to one antiseizure medication during pregnancy had different thinking and learning outcomes than children who were not exposed to antiseizure medicines before birth. The children were ages 3 to 18 years and were born to women in an Australian pregnancy register for antiepileptic drugs.

The study included 110 children without major congenital anomalies. Of these, 91 were exposed in the womb to one medicine only: carbamazepine, lamotrigine, levetiracetam, valproate, or topiramate. Nineteen children were not exposed to antiseizure medicines. A neuropsychologist who did not know which medicine each child had been exposed to gave standardized tests of IQ, school-related skills, memory, language, and executive function.

What they found

Compared with unexposed children, children exposed before birth to valproate, levetiracetam, topiramate, or carbamazepine scored lower across multiple cognitive domains, including processing speed, verbal comprehension, visuospatial reasoning, and academic skills. The largest IQ differences were seen in the topiramate and levetiracetam groups. Children exposed to lamotrigine performed comparably to unexposed children in this study. The study did not find variation in cognitive outcomes by medicine dose, although the authors noted this may reflect smaller sample sizes.

Limits of the evidence

This was not a randomized study, so it cannot show that the medicines caused the differences. The groups were small, especially for topiramate, and that makes the results less certain. Even though the analysis adjusted for factors like maternal IQ, epilepsy characteristics, and relevant perinatal factors, other unmeasured differences could still affect results. The children ranged widely in age, and the study only included children without major congenital anomalies, so the findings may not apply to every pregnancy or every child.

For families and caregivers

For families, this study adds to evidence that some antiseizure medicines used during pregnancy were associated with later differences in learning and thinking in this cohort, while lamotrigine appeared more reassuring. This may help inform pregnancy planning and discussions about medicine choices, but it does not mean a parent should stop or change seizure medicine on their own. Seizure control during pregnancy is also very important, so treatment decisions need to balance benefits and risks.

What to watch next

Larger studies that follow more children for longer could help clarify how specific medicines and doses relate to cognitive outcomes while carefully accounting for family, epilepsy-related, and pregnancy-related factors.

Terms in this summary

antiseizure medication

A medicine used to prevent or reduce seizures.

in utero exposure

When a baby is exposed to something while developing in the womb during pregnancy.

monotherapy

Treatment with just one medicine, not a combination of medicines.

neurocognitive

Related to brain-based skills such as thinking, learning, memory, language, and attention.

IQ

A test score that estimates general thinking and problem-solving ability.

processing speed

How quickly someone can take in information and respond to it.

executive function

Mental skills used for planning, organizing, focusing, and self-control.

cohort study

A study that follows a group of people over time to look for patterns and outcomes.